玻璃体切除术治疗增生性糖尿病视网膜病变110例临床疗效分析  

Clinical analysis of therapeutic effect in treatment of 110 cases of proliferative diabetic retinopathy by vitrectomy

作　　者：张招德[1] 宋晏平[1] 王雨晴[1] 唐涵锋[1] 

机构地区：[1]福建医科大学教学医院宁德市医院,福建宁德352100

出　　处：《中华眼外伤职业眼病杂志》2013年第1期59-61,共3页Chinese Journal of Ocular Trauma and Occupational Eye Disease

摘　　要：目的分析及比较玻璃体切除术治疗不同分期增生性糖尿病视网膜病变（PDR）的疗效。方法对PDR110例（120眼）行玻璃体切除术，其中Ⅳ期、V期及Ⅵ期分别为42例（44眼）、48例（52眼）、20例（24眼），术后平均随访6—12个月，比较随访末各期患者视功能改善率及显效率。结果Ⅳ期、V期及Ⅵ期视功能改善率分别为88．6％、73．1％及54．2％，（x^2=7．163，P=0．026）；显效率分别为93．2％、53．9％及37．5％。（x^2=7．407，P=0．023）。结论玻璃体切除术是治疗增生性糖尿病视网膜病变的有效方法，病变越早手术效果越显著。Objective To analyze and compare the effect of vitrectomy on different stages of prolif- erative diabetic retinopathy （PDR）. Methods Vitrectomy was undergone in 110 cases （120 eyes） of PDR. Phase IV, V and V[ of PDR were in 42 cases （44 eyes） , 48 case （52 eyes） and 20 case（24 eyes）. The improvement rate and effective rate of visual function in every stages were compared after follow-up for 6 - 12 months. Results In phase IV, V and VI of PDR, improvement rates of the visual function were 88.6%, 73.1% and 54.2% （X2 =7. 163, P =0. 026） ; the effective rates were 93.2% , 53.9% and 37.5% （X2 = 7. 407, P = 0. 023）. Conclusion Vitrectomy is the effective method for proliferative diabet- ic retinopathy. The earlier vitrectomy is performed, the effect is more significant.

关 键 词：玻璃体切除术 糖尿病视网膜病变 增生性 疗效 

分 类 号：R779.6[医药卫生—眼科]